Harrow (HROW) Cash & Equivalents (2010 - 2026)
Harrow (HROW) posted quarterly Cash & Equivalents of $94.6 million for Q1 2026, up 41.84% year-over-year from $66.7 million in Q1 2025, and up 29.78% quarter-over-quarter from $72.9 million in Q4 2025.
Harrow (HROW) Cash & Equivalents (2010 - 2026) Analysis & Trends
Harrow's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $94.6 million for Q1 2026.
- In Q1 2026, Cash & Equivalents rose 41.84% year-over-year to $94.6 million; the TTM figure through Mar 2026 stood at $94.6 million (up 41.84% YoY), while the FY2025 annual figure was $72.9 million, up 54.35% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $94.6 million, up from $72.9 million in the prior quarter.
- The five-year high for Cash & Equivalents was $96.3 million in Q4 2022, with the low at $19.2 million in Q1 2023.
- The 5-year median for Cash & Equivalents is $66.7 million (2025), against an average of $60.7 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents surged 544.96% in 2022, then slumped 54.11% in 2023.
- Harrow's Cash & Equivalents stood at $96.3 million in 2022, then fell by 23.04% to $74.1 million in 2023, then slumped by 36.23% to $47.2 million in 2024, then jumped by 54.35% to $72.9 million in 2025, then rose by 29.78% to $94.6 million in 2026.
- Business Quant data shows HROW's Cash & Equivalents at $94.6 million in Q1 2026, $72.9 million in Q4 2025, and $74.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 50.36 Mn | 83.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.89 Mn |
| Mar 31, 2026 | 94.64 Mn |
| Dec 31, 2025 | 72.93 Mn |
| Sep 30, 2025 | 74.29 Mn |
| Jun 30, 2025 | 52.96 Mn |
| Mar 31, 2025 | 66.73 Mn |
| Dec 31, 2024 | 47.25 Mn |
| Sep 30, 2024 | 72.60 Mn |
| Jun 30, 2024 | 70.97 Mn |
| Mar 31, 2024 | 68.54 Mn |
| Dec 31, 2023 | 74.09 Mn |
| Sep 30, 2023 | 65.61 Mn |
| Jun 30, 2023 | 22.75 Mn |
| Mar 31, 2023 | 19.25 Mn |
| Dec 31, 2022 | 96.27 Mn |
| Sep 30, 2022 | 44.96 Mn |
| Jun 30, 2022 | 46.44 Mn |
| Mar 31, 2022 | 41.95 Mn |
| Dec 31, 2021 | 42.17 Mn |
| Sep 30, 2021 | 57.86 Mn |